Viral bronchiolitis

The Lancet

Volumn 389, Issue 10065, 2017, Pages 211-224

  Florin, Todd A ^a,b   Plint, Amy C ^c,d   Zorc, Joseph J ^e,f  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^d UNIVERSITY OF OTTAWA   (Canada)

^e CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; SODIUM CHLORIDE;

ANTIBIOTIC THERAPY; ASSISTED VENTILATION; BLOOD EXAMINATION; CONTROLLED CLINICAL TRIAL (TOPIC); CORTICOSTEROID THERAPY; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; HUMAN; META ANALYSIS (TOPIC); MICROBIOLOGICAL EXAMINATION; NEBULIZATION; NONHUMAN; OXYGEN THERAPY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; PULSE OXIMETRY; REVIEW; SYSTEMATIC REVIEW (TOPIC); URINALYSIS; VIRAL BRONCHIOLITIS; BRONCHIOLITIS, VIRAL; DISEASE MANAGEMENT; MICROBIOLOGY; PEDIATRICS; POSITIVE END EXPIRATORY PRESSURE;

BRONCHIOLITIS, VIRAL; BRONCHODILATOR AGENTS; CONTINUOUS POSITIVE AIRWAY PRESSURE; DISEASE MANAGEMENT; HUMANS; PEDIATRICS; SALINE SOLUTION, HYPERTONIC;

EID: 84995968999     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(16)30951-5     Document Type: Review

References (126)

1. 1 Kyu, HH, Pinho, C, Wagner, JA, et al. Global and national burden of diseases and injuries among children and adolescents between 1990 and 2013: findings from the Global Burden of Disease 2013 Study. JAMA Pediatr 170 (2016), 267–287.
2. 2 Nair, H, Nokes, DJ, Gessner, BD, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 375 (2010), 1545–1555.
3. 3 Pfuntner, A, Wier, L, Stocks, C, Most frequent conditions in US hospitals, 2010. HCUP Statistical Brief #148. http://www.hcup-us.ahrq.gov/reports/statbriefs/sb148.pdf, 2013 (accessed March 30, 2016).
4. 4 Hasegawa, K, Tsugawa, Y, Brown, DF, Mansbach, JM, Camargo, CA Jr, Temporal trends in emergency department visits for bronchiolitis in the United States, 2006 to 2010. Pediatr Infect Dis J 33 (2014), 11–18.
5. 5 Hasegawa, K, Tsugawa, Y, Brown, DF, Mansbach, JM, Camargo, CA Jr, Trends in bronchiolitis hospitalizations in the United States, 2000–2009. Pediatrics 132 (2013), 28–36.
6. 6 Haynes, AK, Prill, MM, Iwane, MK, Gerber, SI, Respiratory syncytial virus—United States, July 2012–June 2014. MMWR Morb Mortal Wkly Rep 63 (2014), 1133–1136.
7. 7 Haynes, AK, Manangan, AP, Iwane, MK, et al. Respiratory syncytial virus circulation in seven countries with Global Disease Detection Regional Centers. J Infect Dis 208:suppl 3 (2013), S246–S254.
8. 8 Meissner, HC, Viral bronchiolitis in children. N Engl J Med 374 (2016), 62–72.
9. 9 Foxman, EF, Storer, JA, Fitzgerald, ME, et al. Temperature-dependent innate defense against the common cold virus limits viral replication at warm temperature in mouse airway cells. Proc Natl Acad Sci USA 112 (2015), 827–832.
10. 10 Salah, B, Dinh Xuan, AT, Fouilladieu, JL, Lockhart, A, Regnard, J, Nasal mucociliary transport in healthy subjects is slower when breathing dry air. Eur Respir J 1 (1988), 852–855.
11. 11 Wang, VJ, Cavagnaro, CS, Clark, S, Camargo, CA Jr, Mansbach, JM, Altitude and environmental climate effects on bronchiolitis severity among children presenting to the emergency department. J Environ Health 75 (2012), 8–15.
12. 12 Yusuf, S, Piedimonte, G, Auais, A, et al. The relationship of meteorological conditions to the epidemic activity of respiratory syncytial virus. Epidemiol Infect 135 (2007), 1077–1090.
13. 13 Darrow, LA, Klein, M, Flanders, WD, Mulholland, JA, Tolbert, PE, Strickland, MJ, Air pollution and acute respiratory infections among children 0–4 years of age: a 1–8 year time-series study. Am J Epidemiol 180 (2014), 968–977.
14. 14 Kim, BJ, Seo, JH, Jung, YH, et al. Air pollution interacts with past episodes of bronchiolitis in the development of asthma. Allergy 68 (2013), 517–523.
15. 15 Rice, MB, Rifas-Shiman, SL, Oken, E, et al. Exposure to traffic and early life respiratory infection: a cohort study. Pediatr Pulmonol, 2014, 10.1002/ppul.23029 published online March 27.
16. 16 DiFranza, JR, Masaquel, A, Barrett, AM, Colosia, AD, Mahadevia, PJ, Systematic literature review assessing tobacco smoke exposure as a risk factor for serious respiratory syncytial virus disease among infants and young children. BMC Pediatr, 12, 2012, 81.
17. 17 Bradley, JP, Bacharier, LB, Bonfiglio, J, et al. Severity of respiratory syncytial virus bronchiolitis is affected by cigarette smoke exposure and atopy. Pediatrics 115 (2005), e7–14.
18. 18 Stockman, LJ, Curns, AT, Anderson, LJ, Fischer-Langley, G, Respiratory syncytial virus-associated hospitalizations among infants and young children in the United States, 1997–2006. Pediatr Infect Dis J 31 (2012), 5–9.
19. 19 Hall, CB, Weinberg, GA, Blumkin, AK, et al. Respiratory syncytial virus-associated hospitalizations among children less than 24 months of age. Pediatrics 132 (2013), e341–e348.
20. 20 Schuurhof, A, Bont, L, Siezen, CL, et al. Interleukin-9 polymorphism in infants with respiratory syncytial virus infection: an opposite effect in boys and girls. Pediatr Pulmonol 45 (2010), 608–613.
21. 21 Ali, S, Plint, AC, Klassen, TP, Bronchiolitis. Wilmott, RW, Kendig, EL, Boat, TF, Bush, A, Chernick, V, (eds.) Kendig and Chernick's disorders of the respiratory tract in children, 8th edn., 2012, Elsevier Saunders, Philadelphia, 443–452.
22. 22 Aherne, W, Bird, T, Court, SD, Gardner, PS, McQuillin, J, Pathological changes in virus infections of the lower respiratory tract in children. J Clin Pathol 23 (1970), 7–18.
23. 23 Mansbach, JM, Camargo, CA Jr, Bronchiolitis: lingering questions about its definition and the potential role of vitamin D. Pediatrics 122 (2008), 177–179.
24. 24 Calvo, C, Pozo, F, Garcia-Garcia, ML, et al. Detection of new respiratory viruses in hospitalized infants with bronchiolitis: a three-year prospective study. Acta Paediatr 99 (2010), 883–887.
25. 25 Midulla, F, Scagnolari, C, Bonci, E, et al. Respiratory syncytial virus, human bocavirus and rhinovirus bronchiolitis in infants. Arch Dis Child 95 (2010), 35–41.
26. 26 Marguet, C, Lubrano, M, Gueudin, M, et al. In very young infants severity of acute bronchiolitis depends on carried viruses. PLoS One, 4, 2009, e4596.
27. 27 Miller, EK, Gebretsadik, T, Carroll, KN, et al. Viral etiologies of infant bronchiolitis, croup and upper respiratory illness during 4 consecutive years. Pediatr Infect Dis J 32 (2013), 950–955.
28. 28 Skjerven, HO, Megremis, S, Papadopoulos, NG, Mowinckel, P, Carlsen, KH, Lodrup Carlsen, KC, Virus type and genomic load in acute bronchiolitis: severity and treatment response with inhaled adrenaline. J Infect Dis 213 (2016), 915–921.
29. 29 Mansbach, JM, McAdam, AJ, Clark, S, et al. Prospective multicenter study of the viral etiology of bronchiolitis in the emergency department. Acad Emerg Med 15 (2008), 111–118.
30. 30 Mansbach, JM, Piedra, PA, Teach, SJ, et al. Prospective multicenter study of viral etiology and hospital length of stay in children with severe bronchiolitis. Arch Pediatr Adolesc Med 166 (2012), 700–706.
31. 31 Hasegawa, K, Jartti, T, Mansbach, JM, et al. Respiratory syncytial virus genomic load and disease severity among children hospitalized with bronchiolitis: multicenter cohort studies in the United States and Finland. J Infect Dis 211 (2015), 1550–1559.
32. 32 Scagnolari, C, Midulla, F, Selvaggi, C, et al. Evaluation of viral load in infants hospitalized with bronchiolitis caused by respiratory syncytial virus. Med Microbiol Immunol 201 (2012), 311–317.
33. 33 Papadopoulos, NG, Moustaki, M, Tsolia, M, et al. Association of rhinovirus infection with increased disease severity in acute bronchiolitis. Am J Respir Crit Care Med 165 (2002), 1285–1289.
34. 34 Semple, MG, Cowell, A, Dove, W, et al. Dual infection of infants by human metapneumovirus and human respiratory syncytial virus is strongly associated with severe bronchiolitis. J Infect Dis 191 (2005), 382–386.
35. 35 Jansen, RR, Wieringa, J, Koekkoek, SM, et al. Frequent detection of respiratory viruses without symptoms: toward defining clinically relevant cutoff values. J Clin Microbiol 49 (2011), 2631–2636.
36. 36 Hasegawa, K, Linnemann, RW, Avadhanula, V, et al. Detection of respiratory syncytial virus and rhinovirus in healthy infants. BMC Res Notes, 8, 2015, 718.
37. 37 Self, WH, Williams, DJ, Zhu, Y, et al. Respiratory viral detection in children and adults: comparing asymptomatic controls and patients with community-acquired pneumonia. J Infect Dis 213 (2016), 584–591.
38. 38 Bronchiolitis in children: diagnosis and management. NICE guideline. https://www.nice.org.uk/Guidance/NG9, 2015 (accessed March 30, 2016).
39. 39 Ralston, SL, Lieberthal, AS, Meissner, HC, et al. Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis. Pediatrics 134 (2014), e1474–e1502.
40. 40 Court, SD, The definition of acute respiratory illnesses in children. Postgrad Med J 49 (1973), 771–776.
41. 41 Plint, AC, Grenon, R, Klassen, TP, Johnson, DW, Bronchodilator and steroid use for the management of bronchiolitis in Canadian pediatric emergency departments. CJEM 17 (2015), 46–53.
42. 42 Fernandes, RM, Plint, AC, Terwee, CB, et al. Validity of bronchiolitis outcome measures. Pediatrics 135 (2015), e1399–e1408.
43. 43 McCallum, GB, Morris, PS, Wilson, CC, et al. Severity scoring systems: are they internally valid, reliable and predictive of oxygen use in children with acute bronchiolitis?. Pediatr Pulmonol 48 (2013), 797–803.
44. 44 Willwerth, BM, Harper, MB, Greenes, DS, Identifying hospitalized infants who have bronchiolitis and are at high risk for apnea. Ann Emerg Med 48 (2006), 441–447.
45. 45 Friedman, JN, Rieder, MJ, Walton, JM, Bronchiolitis: recommendations for diagnosis, monitoring and management of children one to 24 months of age. Paediatr Child Health 19 (2014), 485–498.
46. 46 Scottish Intercollegiate Guidelines Network (SIGN). Bronchiolitis in children: a national clinical guideline. http://sign.ac.uk/guidelines/fulltext/91/index.html, 2006 (accessed March 30, 2016).
47. 47 Baraldi, E, Lanari, M, Manzoni, P, et al. Inter-society consensus document on treatment and prevention of bronchiolitis in newborns and infants. Ital J Pediatr, 40, 2014, 65.
48. 48 Working Group of the Clinical Practice Guideline on Acute Bronchiolitis. Quality plan for the Spanish national healthcare system of the Spanish Ministry for Health and Social Policy; Catalan Agency for Health Technology Assessment, 2010. Clinical Practice Guidelines in the Spanish National Healthcare System: CAHTA no. 2007/05.
49. 49 Turner, T, Wilkinson, F, Harris, C, Mazza, D, Evidence based guidelines for the management of bronchiolitis. Aust Fam Physician 37 (2008), 6–13.
50. 50 Verstraete, M, Cros, P, Gouin, M, et al. Prise en charge de la bronchiolite aiguë du nourrisson de moins 1 an: actualization et consensus medical au sein des hôpitaux universitaires du Grand Ouest (HUGO). Arch Pediatr 21 (2014), 53–62.
51. 51 Schuh, S, Freedman, S, Coates, A, et al. Effect of oximetry on hospitalization in bronchiolitis: a randomized clinical trial. JAMA 312 (2014), 712–718.
52. 52 Cunningham, S, Rodriguez, A, Adams, T, et al. Oxygen saturation targets in infants with bronchiolitis (BIDS): a double-blind, randomised, equivalence trial. Lancet 386 (2015), 1041–1048.
53. 53 McCulloh, R, Koster, M, Ralston, S, et al. Use of intermittent vs continuous pulse oximetry for non-hypoxemic infants and young children hospitalized for bronchiolitis: a randomized clinical trial. JAMA Pediatr 169 (2015), 898–904.
54. 54 Principi, T, Coates, AL, Parkin, PC, Stephens, D, DaSilva, Z, Schuh, S, Effect of oxygen desaturations on subsequent medical visits in infants discharged from the emergency department with bronchiolitis. JAMA Pediatr 170 (2016), 602–608.
55. 55 Mahabee-Gittens, EM, Bachman, DT, Shapiro, ED, Dowd, MD, Chest radiographs in the pediatric emergency department for children < or = 18 months of age with wheezing. Clin Pediatr (Phila) 38 (1999), 395–399.
56. 56 Mathews, B, Shah, S, Cleveland, RH, Lee, EY, Bachur, RG, Neuman, MI, Clinical predictors of pneumonia among children with wheezing. Pediatrics 124 (2009), e29–e36.
57. 57 Ecochard-Dugelay, E, Beliah, M, Perreaux, F, et al. Clinical predictors of radiographic abnormalities among infants with bronchiolitis in a paediatric emergency department. BMC Pediatr, 14, 2014, 143.
58. 58 Schuh, S, Lalani, A, Allen, U, et al. Evaluation of the utility of radiography in acute bronchiolitis. J Pediatr 150 (2007), 429–433.
59. 59 Ecochard-Dugelay, E, Beliah, M, Boisson, C, et al. Impact of chest radiography for children with lower respiratory tract infection: a propensity score approach. PLoS One, 9, 2014, e96189.
60. 60 Mahabee-Gittens, EM, Dowd, MD, Beck, JA, Smith, SZ, Clinical factors associated with focal infiltrates in wheezing infants and toddlers. Clin Pediatr (Phila) 39 (2000), 387–393.
61. 61 Caiulo, VA, Gargani, L, Caiulo, S, et al. Lung ultrasound in bronchiolitis: comparison with chest X-ray. Eur J Pediatr 170 (2011), 1427–1433.
62. 62 Basile, V, Di Mauro, A, Scalini, E, et al. Lung ultrasound: a useful tool in diagnosis and management of bronchiolitis. BMC Pediatr, 15, 2015, 63.
63. 63 Stollar, F, Alcoba, G, Gervaix, A, Argiroffo, CB, Virologic testing in bronchiolitis: does it change management decisions and predict outcomes?. Eur J Pediatr 173 (2014), 1429–1435.
64. 64 Nenna, R, Ferrara, M, Nicolai, A, et al. Viral load in infants hospitalized for respiratory syncytial virus bronchiolitis correlates with recurrent wheezing at thirty-six-month follow-up. Pediatr Infect Dis J 34 (2015), 1131–1132.
65. 65 Hall, CB, The spread of influenza and other respiratory viruses: complexities and conjectures. Clin Infect Dis 45 (2007), 353–359.
66. 66 Fabian M, McDevitt J, Milton D. Modes of transmission of respiratory viral infections. In: Johnston SL, O'Byrne P, eds. Exacerbations of asthma. Boston: exposure, epidemiology risk program. Department of Environmental Health Harvard School of Public Health, 2005: 2007: 1–2.
67. 67 Brankston, G, Gitterman, L, Hirji, Z, Lemieux, C, Gardam, M, Transmission of influenza A in human beings. Lancet Infect Dis 7 (2007), 257–265.
68. 68 Levine, DA, Platt, SL, Dayan, PS, et al. Risk of serious bacterial infection in young febrile infants with respiratory syncytial virus infections. Pediatrics 113 (2004), 1728–1734.
69. 69 Purcell, K, Fergie, J, Lack of usefulness of an abnormal white blood cell count for predicting a concurrent serious bacterial infection in infants and young children hospitalized with respiratory syncytial virus lower respiratory tract infection. Pediatr Infect Dis J 26 (2007), 311–315.
70. 70 Librizzi, J, McCulloh, R, Koehn, K, Alverson, B, Appropriateness of testing for serious bacterial infection in children hospitalized with bronchiolitis. Hosp Pediatr 4 (2014), 33–38.
71. 71 Ralston, S, Hill, V, Waters, A, Occult serious bacterial infection in infants younger than 60 to 90 days with bronchiolitis a systematic review. Arch Pediat Adol Med 165 (2011), 951–956.
72. 72 Elkhunovich, MA, Wang, VJ, Assessing the utility of urine testing in febrile infants aged 2 to 12 months with bronchiolitis. Pediatr Emerg Care 31 (2015), 616–620.
73. 73 Roberts, KB, Urinary tract infection: clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months. Pediatrics 128 (2011), 595–610.
74. 74 Mazur, NI, Martinón-Torres, F, Baraldi, E, et al. Lower respiratory tract infection caused by respiratory syncytial virus: current management and new therapeutics. Lancet Respir Med 3 (2015), 888–900.
75. 75 Gadomski, AM, Scribani, MB, Bronchodilators for bronchiolitis. Cochrane Database Syst Rev, 6, 2014 CD001266.
76. 76 Hartling, L, Bialy, LM, Vandermeer, B, et al. Epinephrine for bronchiolitis. Cochrane Database Syst Rev, 6, 2011 CD003123.
77. 77 Skjerven, HO, Hunderi, JO, Brugmann-Pieper, SK, et al. Racemic adrenaline and inhalation strategies in acute bronchiolitis. N Engl J Med 368 (2013), 2286–2293.
78. 78 Mandelberg, A, Amirav, I, Hypertonic saline or high volume normal saline for viral bronchiolitis: mechanisms and rationale. Pediatr Pulmonol 45 (2010), 36–40.
79. 79 Wills, PJ, Hall, RL, Chan, W, Cole, PJ, Sodium chloride increases the ciliary transportability of cystic fibrosis and bronchiectasis sputum on the mucus-depleted bovine trachea. J Clin Invest 99 (1997), 9–13.
80. 80 Donaldson, SH, Hydrator therapies for cystic fibrosis lung disease. Pediatric Pulmonology 43 (2008), S18–S23.
81. 81 Mandelberg, A, Tal, G, Witzling, M, et al. Nebulized 3% hypertonic saline solution treatment in hospitalized infants with viral bronchiolitis. Chest 123 (2003), 481–487.
82. 82 Kuzik, BA, Al-Qadhi, SA, Kent, S, et al. Nebulized hypertonic saline in the treatment of viral bronchiolitis in infants. J Pediatr 151 (2007), 266–270.
83. 83 Luo, Z, Liu, E, Luo, J, et al. Nebulized hypertonic saline/salbutamol solution treatment in hospitalized children with mild to moderate bronchiolitis. Pediatr Int 52 (2010), 199–202.
84. 84 Wu, S, Baker, C, Lang, ME, et al. Nebulized hypertonic saline for bronchiolitis: a randomized clinical trial. JAMA Pediatr 168 (2014), 657–663.
85. 85 Florin, TA, Shaw, KN, Kittick, M, Yakscoe, S, Zorc, JJ, Nebulized hypertonic saline for bronchiolitis in the emergency department: a randomized clinical trial. JAMA Pediatr 168 (2014), 664–670.
86. 86 Grewal, S, Klassen, TP, The tale of 2 trials: disentangling contradictory evidence on hypertonic saline for acute bronchiolitis. JAMA Pediatr 168 (2014), 607–609.
87. 87 Silver, AH, Esteban-Cruciani, N, Azzarone, G, et al. 3% hypertonic saline versus normal saline in inpatient bronchiolitis: a randomized controlled trial. Pediatrics 136 (2015), 1036–1043.
88. 88 Flores, P, Mendes, AL, Neto, AS, A randomized trial of nebulized 3% hypertonic saline with salbutamol in the treatment of acute bronchiolitis in hospitalized infants. Pediatr Pulmonol 51 (2016), 418–425.
89. 89 Everard, ML, Hind, D, Ugonna, K, et al. SABRE: a multicentre randomised control trial of nebulised hypertonic saline in infants hospitalised with acute bronchiolitis. Thorax 69 (2014), 1105–1112.
90. 90 Teunissen, J, Hochs, AH, Vaessen-Verberne, A, et al. The effect of 3% and 6% hypertonic saline in viral bronchiolitis: a randomised controlled trial. Eur Respir J 44 (2014), 913–921.
91. 91 Zhang, L, Mendoza-Sassi, RA, Klassen, TP, Wainwright, C, Nebulized hypertonic saline for acute bronchiolitis: a systematic review. Pediatrics 136 (2015), 687–701.
92. 92 Maguire, C, Cantrill, H, Hind, D, Bradburn, M, Everard, ML, Hypertonic saline (HS) for acute bronchiolitis: systematic review and meta-analysis. BMC Pulm Med, 15, 2015, 148.
93. 93 Brooks, CG, Harrison, WN, Ralston, SL, Association between hypertonic saline and hospital length of stay in acute viral bronchiolitis: a reanalysis of 2 meta-analyses. JAMA Pediatr 170 (2016), 577–584.
94. 94 Corneli, HM, Zorc, JJ, Mahajan, P, et al. A multicenter, randomized, controlled trial of dexamethasone for bronchiolitis. N Engl J Med 357 (2007), 331–339.
95. 95 Plint, AC, Johnson, DW, Patel, H, et al. Epinephrine and dexamethasone in children with bronchiolitis. N Engl J Med 360 (2009), 2079–2089.
96. 96 Fernandes, RM, Bialy, LM, Vandermeer, B, et al. Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database Syst Rev, 6, 2013 CD004878.
97. 97 Sinha, IP, McBride, AK, Smith, R, Fernandes, RM, CPAP and high-flow nasal cannula oxygen in bronchiolitis. Chest 148 (2015), 810–823.
98. 98 Bueno Campana, M, Olivares Ortiz, J, Notario Munoz, C, et al. High flow therapy versus hypertonic saline in bronchiolitis: randomised controlled trial. Arch Dis Child 99 (2014), 511–515.
99. 99 Farley, R, Spurling, GK, Eriksson, L, Del Mar, CB, Antibiotics for bronchiolitis in children under two years of age. Cochrane Database Syst Rev, 10, 2014 CD005189.
100. 100 Andrade, MA, Hoberman, A, Glustein, J, Paradise, JL, Wald, ER, Acute otitis media in children with bronchiolitis. Pediatrics 101 (1998), 617–619.
101. 101 Shazberg, G, Revel-Vilk, S, Shoseyov, D, Ben-Ami, A, Klar, A, Hurvitz, H, The clinical course of bronchiolitis associated with acute otitis media. Arch Dis Child 83 (2000), 317–319.
102. 102 Lieberthal, AS, Carroll, AE, Chonmaitree, T, et al. The diagnosis and management of acute otitis media. Pediatrics 131 (2013), e964–e999.
103. 103 McCallum, GB, Morris, PS, Chatfield, MD, et al. A single dose of azithromycin does not improve clinical outcomes of children hospitalised with bronchiolitis: a randomised, placebo-controlled trial. PLoS One, 8, 2013, e74316.
104. 104 Pinto, LA, Pitrez, PM, Luisi, F, et al. Azithromycin therapy in hospitalized infants with acute bronchiolitis is not associated with better clinical outcomes: a randomized, double-blinded, and placebo-controlled clinical trial. J Pediatr 161 (2012), 1104–1108.
105. 105 Beigelman, A, Isaacson-Schmid, M, Sajol, G, et al. Randomized trial to evaluate azithromycin's effects on serum and upper airway IL-8 levels and recurrent wheezing in infants with respiratory syncytial virus bronchiolitis. J Allergy Clin Immunol 135 (2015), 1171–1178.
106. 106 Bacharier, LB, Guilbert, TW, Mauger, DT, et al. Early administration of azithromycin and prevention of severe lower respiratory tract illnesses in preschool children with a history of such illnesses: a randomized clinical trial. JAMA 314 (2015), 2034–2044.
107. 107 Oakley, E, Borland, M, Neutze, J, et al., for the Paediatric Research in Emergency Departments International Collaborative (PREDICT). Nasogastric hydration versus intravenous hydration for infants with bronchiolitis: a randomised trial. Lancet Respir Med 1 (2013), 113–120.
108. 108 Mussman, GM, Parker, MW, Statile, A, Sucharew, H, Brady, PW, Suctioning and length of stay in infants hospitalized with bronchiolitis. JAMA Pediatr 167 (2013), 414–421.
109. 2 saturation in infants with bronchiolitis?. Arch Dis Child 101 (2016), 114–115.
110. 110 Schreiber, S, Ronfani, L, Ghirardo, S, et al. Nasal irrigation with saline solution significantly improves oxygen saturation in infants with bronchiolitis. Acta Paediatr 105 (2016), 292–296.
111. 111 Ralston, S, Garber, M, Narang, S, et al. Decreasing unnecessary utilization in acute bronchiolitis care: results from the value in inpatient pediatrics network. J Hosp Med 8 (2013), 25–30.
112. 112 Gajdos, V, Katsahian, S, Beydon, N, et al. Effectiveness of chest physiotherapy in infants hospitalized with acute bronchiolitis: a multicenter, randomized, controlled trial. PLoS Med, 7, 2010, e1000345.
113. 113 Roqué i Figuls, M, Giné-Garriga, M, Granados Rugeles, C, Perrotta, C, Vilaró, J, Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old. Cochrane Database Syst Rev, 2, 2016 CD004873.
114. 114 Carlsen, KH, Larsen, S, Bjerve, O, Leegaard, J, Acute bronchiolitis: predisposing factors and characterization of infants at risk. Pediatr Pulmonol 3 (1987), 153–160.
115. 115 Sigurs, N, Aljassim, F, Kjellman, B, et al. Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life. Thorax 65 (2010), 1045–1052.
116. 116 Stein, RT, Sherrill, D, Morgan, WJ, et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 354 (1999), 541–545.
117. 117 Fjaerli, HO, Farstad, T, Rod, G, Ufert, GK, Gulbrandsen, P, Nakstad, B, Acute bronchiolitis in infancy as risk factor for wheezing and reduced pulmonary function by seven years in Akershus County, Norway. BMC Pediatr, 5, 2005, 31.
118. 118 Jeng, MJ, Lee, YS, Tsao, PC, Yang, CF, Soong, WJ, A longitudinal study on early hospitalized airway infections and subsequent childhood asthma. PLoS One, 10, 2014, e0121906.
119. 119 Carroll, KN, Wu, P, Gebretsadik, T, et al. The severity-dependent relationship of infant bronchiolitis on the risk and morbidity of early childhood asthma. J Allergy Clin Immunol, 123, 2009, 1055 61.e1.
120. 120 Everard, ML, Hind, D, Ugonna, K, et al. Saline in acute bronchiolitis RCT and economic evaluation: hypertonic saline in acute bronchiolitis—randomised controlled trial and systematic review. Health Technol Assess 19 (2015), 1–130.
121. 121 Greening, AP, Ind, PW, Northfield, M, Shaw, G, Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group. Lancet 344 (1994), 219–224.
122. 122 Pauwels, RA, Lofdahl, CG, Postma, DS, et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med 337 (1997), 1405–1411.
123. 123 Barnes, PJ, Scientific rationale for using a single inhaler for asthma control. Eur Respir J 29 (2007), 587–595.
124. 124 Giembycz, MA, Kaur, M, Leigh, R, Newton, R, A holy grail of asthma management: toward understanding how long-acting beta(2)-adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids. Br J Pharmacol 153 (2008), 1090–1104.
125. 125 Kaur, M, Chivers, JE, Giembycz, MA, Newton, R, Long-acting beta 2-adrenoceptor agonists synergistically enhance glucocorticoid-dependent transcription in human airway epithelial and smooth muscle cells. Mol Pharmacol 73 (2008), 203–214.
126. 126 Holden, NS, Bell, MJ, Rider, CF, et al. Beta 2-adrenoceptor agonist-induced RGS2 expression is a genomic mechanism of bronchoprotection that is enhanced by glucocorticoids. Proc Natl Acad Sci USA 108 (2011), 19713–19718.